Peter Benedict's most recent trade in Usana Health Sciences Inc was a trade of 15,625 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 15,625 | 24,119 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 1,157 | 8,494 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 1,157 | 2,652 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 658 | 1,724 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 658 | 9,651 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 08 Feb 2025 | 401 | 2,251 (0%) | 0% | 30.7 | 12,291 | Common Stock |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 08 Feb 2025 | 229 | 1,495 (0%) | 0% | 30.7 | 7,019 | Common Stock |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,001 | 1,001 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,001 | 10,941 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 632 | 1,286 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 632 | 10,309 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.21 per share. | 06 Feb 2025 | 347 | 654 (0%) | 0% | 31.2 | 10,830 | Common Stock |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 06 Feb 2025 | 220 | 1,066 (0%) | 0% | 30.7 | 6,743 | Common Stock |
| Usana Health Sciences Inc | Peter Benedict | CHIEF INFORMATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 2,391 | 16,462 | - | - | Restricted Stock Units |